HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Remifentanil, ketamine, and fospropofol: a review of alterative continuous infusion agents for sedation in the critically ill.

Abstract
Sedation and analgesia are integral aspects in the care of critically ill patients admitted to the intensive care unit. In recent years, many of the commonly used sedative agents in the United States have experienced manufacturing and sterility issues leading to decreased availability. In addition, current practice has shifted to providing lighter levels of sedation as clinicians have gained a better understanding of the consequences of prolonged deep sedation. Benzodiazepines have fallen out of favor due to findings including increased delirium and duration of mechanical ventilation. Alterations in end-organ function in critically ill patients may also lead to varied responses to commonly used sedatives. With numerous factors impacting choice of sedation in the intensive care unit, fospropofol, ketamine, and remifentanil have been considered potential alternatives to standard therapy. The purpose of this review was to discuss strategies for the safe and effective use of fospropofol, ketamine, and remifentanil for continuous intravenous sedation in critically ill patients.
AuthorsKerry M Mohrien, G Morgan Jones, Jennifer R MacDermott, Claire V Murphy
JournalCritical care nursing quarterly (Crit Care Nurs Q) 2014 Apr-Jun Vol. 37 Issue 2 Pg. 137-51 ISSN: 1550-5111 [Electronic] United States
PMID24595251 (Publication Type: Journal Article, Review)
Chemical References
  • Hypnotics and Sedatives
  • Piperidines
  • Ketamine
  • fospropofol
  • Remifentanil
  • Propofol
Topics
  • Conscious Sedation (methods)
  • Critical Care (methods)
  • Critical Illness (therapy)
  • Female
  • Humans
  • Hypnotics and Sedatives (administration & dosage)
  • Infusions, Intravenous
  • Intensive Care Units
  • Ketamine (administration & dosage)
  • Male
  • Piperidines (administration & dosage)
  • Propofol (administration & dosage, analogs & derivatives)
  • Remifentanil
  • Respiration, Artificial (methods)
  • Treatment Outcome
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: